Policy
In a Cabinet meeting, Health Secretary Robert F. Kennedy Jr. said the website could go live “probably in the next 10 days,” but an exact launch date remains unclear.
FEATURED STORIES
An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation threaten the U.S.’s half-century-long dominance in the biotech sector.
Acadia Pharma’s Catherine Owen Adams is one of the founders of a group of small- to mid-cap biotechs advocating against a ‘peanut butter blanket’ approach to drug pricing for small companies.
Former European Trade Commissioner Phil Hogan and former U.S. Senator Richard Burr, speaking on a panel at the J.P. Morgan Healthcare Conference, pushed to see a larger picture beyond the Trump administration’s year of chaos and confusion.
Subscribe to BioPharm Executive
Market insights and trending stories for biopharma leaders, in your inbox every Wednesday
THE LATEST
Government officials say they are now certain they know who launched the NotPetya cyberwar that slammed operations at Merck last year.
The company submitted the infringement suit this week to the U.S. District Court for the Southern District of California.
Shares of Pacira plunged more than 15 percent this morning after the company revealed the FDA panel’s decision.
The company is addressing the FDA’s complaints regarding manufacturing practices, which stem from a routine inspection in January,
The 60-year-old chemist has been charged with stealing 219.79 grams of potassium cyanide from a Merck facility in Pennsylvania.
Alzheimer’s drug development took another hit.
Bob Hugin announced his campaign on Monday in an email.
Resubmission of NDA for Firdapse on schedule for end of the first quarter.
The lawsuit alleged that Insulet misrepresented the success of its OmniPod Eros roll-out in 2013.
The federal watchdog has cleared the updated design and labeling for the duodenoscope.